iScience Interventional Secures Debt Facility from Square 1 Bank

Medical device company iScience Interventional has secured a $5 million debt facility from Square 1 Bank. iScience specializes in the discovery and development of interventional therapies and procedures targeting ophthalmic diseases.

PRESS RELEASE

Square 1 Bank, the
exclusive banking partner to entrepreneurs and the venture capital
community, is pleased to provide a $5 million debt facility to iScience
Interventional, Inc., a medical device company specializing in the
discovery and development of interventional therapies and procedures
targeting ophthalmic diseases.

“iScience is excited to have Square 1 Bank as a partner in providing a
wealth of financial services to support our mission,” said Mike Nash,
iScience CEO.

James Branski, iScience CFO added, “The team at Square 1 Bank provided
the optimal debt facility to fund our distribution expansion plan and
support future product platforms for restoring sight to our patients.
They executed flawlessly and expeditiously as we transitioned our
financial services to Square 1 Bank.”

“iScience is developing game changing technologies that could redefine
the standard of care for patients dealing with ocular disease,”
commented Scott Foote, SVP and Managing Director of Square 1 Bank’s
Life Sciences West division. “With their impressive investors and
pioneering developments, we’re pleased to add iScience to the roster of
innovative companies banking with Square 1.”

About Square 1 Bank

Square 1 Bank is a full service commercial bank dedicated exclusively
to serving the financial needs of the venture capital community and
entrepreneurs in all stages of growth and expansion. Square 1’s
expertise, focus and strong capital base provide solid support for its
clients’ needs. The bank offers tailored products and solutions aided
by the latest in technological innovations. To serve its relationships,
Square 1 has offices coast to coast in Austin, Boston, Boulder, Durham,
McLean, New York, San Diego, Santa Monica, Seattle, and Silicon Valley.

About iScience Interventional

Founded in 1999 with headquarters in Menlo Park, California, iScience
Interventional(TM) is a science, technology, and patient outcome-driven
medical device company that specializes in the development of
leading-edge, interventional therapies and procedures for ophthalmic
diseases. Our mission is to research, discover, and develop
technologies that enable ophthalmologists to advance how eye diseases
are addressed and managed. iScience Interventional(TM) was the first
company to develop microcatheter and high-resolution imaging systems
that enable ophthalmologists to perform true site-specific therapy